Alumis And Kaken Pharmaceutical Announce Collaboration And Licensing Agreement For ESK-001 In Dermatology In Japan
March 25 (Reuters) - Alumis Inc ALMS.O:
ALUMIS AND KAKEN PHARMACEUTICAL ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR ESK-001 IN DERMATOLOGY IN JAPAN
ALUMIS INC - TO RECEIVE $40 MILLION UPFRONT, POTENTIAL $140 MILLION IN MILESTONE PAYMENTS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.